Advanced PRP Treatment in Dubai

The blood draw for PRP is similar to a routine blood test and causes minimal discomfort. The PRP injection itself may cause temporary pressure or mild pain at the treatment site. We use local anesthesia when injecting into sensitive areas to minimize discomfort. Post-procedure soreness at the injection site is common for 24 to 72 hours and is actually a positive sign that the healing cascade has been initiated. Acetaminophen can be used for comfort, but anti-inflammatory medications should be avoided as they counteract the PRP's mechanism of action.

The number of PRP sessions varies by condition and individual response. Many patients experience meaningful improvement after a single injection, particularly for conditions like tennis elbow. Chronic tendinopathy or moderate osteoarthritis may benefit from a series of 2 to 3 injections spaced 4 to 6 weeks apart. Your orthopedic specialist will evaluate your response after the initial treatment and recommend additional sessions only if clinically indicated. Some patients return for annual maintenance treatments to sustain their results.

PRP is not an instant pain reliever. It works by stimulating your body's natural repair mechanisms at the cellular level. Initial improvement is typically noticed within 2 to 4 weeks as inflammation subsides and tissue regeneration begins. Continued improvement occurs over 2 to 3 months as new collagen forms and matures. Maximum benefit is usually achieved by 3 to 6 months after treatment. This timeline reflects genuine tissue healing rather than temporary symptom suppression, which is why PRP often provides longer-lasting relief than cortisone injections.

Since PRP is prepared from your own blood, the risk of allergic reaction, immune rejection, or disease transmission is virtually zero. Common temporary side effects include localized soreness, mild swelling, and stiffness at the injection site lasting 1 to 3 days. Some patients experience a temporary increase in pain before improvement begins. Infection risk is extremely low due to strict sterile protocols. There are no known systemic side effects because the treatment is entirely autologous and localized.

Yes, most patients drive themselves home after PRP treatment. The procedure does not involve sedation or general anesthesia. However, if PRP was injected into your driving foot or ankle, or if you experience significant discomfort, arranging alternative transportation is recommended. We advise resting the treated area for the remainder of the day and avoiding strenuous activity for 48 hours following the injection.

Anti-inflammatory medications such as ibuprofen, naproxen, and aspirin should be stopped at least 7 days before PRP treatment because they impair platelet function and reduce the treatment's effectiveness. After PRP injection, continue avoiding anti-inflammatories for at least 2 weeks to allow the healing response to proceed unimpeded. Blood thinners should be discussed with your doctor, as adjustments may be needed. Acetaminophen (paracetamol) is safe to use before and after PRP for pain management.

Cortisone injections provide fast anti-inflammatory relief within days but offer temporary symptom suppression lasting weeks to months, and repeated use can weaken tendons and cartilage. PRP takes longer to show effects, typically 2 to 4 weeks, but promotes actual tissue repair and regeneration rather than just reducing inflammation. Studies on tennis elbow show that PRP provides superior long-term outcomes compared to cortisone at 6 and 12 months. For acute inflammatory flare-ups, cortisone may be preferred. For chronic conditions, PRP often provides more durable improvement.

Success rates vary by condition. For chronic lateral epicondylitis (tennis elbow), studies report improvement in 70 to 80 percent of patients with PRP. For knee osteoarthritis, research shows significant pain reduction and functional improvement in 60 to 70 percent of patients with mild to moderate disease. Achilles tendinopathy and plantar fasciitis show similarly encouraging results. Success depends on proper patient selection, condition severity, platelet preparation quality, and adherence to post-treatment guidelines. Advanced conditions may have lower response rates.